{ }
001122334455554433221100
001122334455554433221100

gene therapy market poised for growth driven by innovation and collaboration

The global gene therapy market, valued at $7.54 billion in 2022, is projected to reach $41.38 billion by 2031, driven by increased R&D, favorable regulations, and collaborations between pharmaceutical companies and academic institutions. North America leads the market, with significant advancements in biotechnology and numerous clinical trials. Recent developments include Novartis's acquisition of a gene therapy candidate from Avrobio and Bristol-Myers Squibb's expansion of its cell therapy manufacturing network.

Nanotechnology in Medicine and Healthcare Market Forecast and Growth Opportunities 2024 to 2031

The Nanotechnology in Medicine and Healthcare Market report provides a comprehensive analysis of market trends, growth opportunities, and competitive dynamics from 2024 to 2031. It covers key segments, including nanoparticles and drug delivery applications, while offering insights into major players like Abbott Laboratories and Johnson & Johnson. The report also includes a SWOT analysis and highlights regional consumption patterns, aiding stakeholders in strategic decision-making.

Biocon shares surge after US FDA approves Yesintek biosimilar for treatment

Biocon shares surged over 4% following the U.S. FDA's approval of Yesintek, a biosimilar to J&J's Stelara, for treating Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis. The stock has risen 47% year-to-date, outperforming the Nifty 50's 11% increase. This marks the seventh consecutive day of gains for Biocon, which has a licensing agreement with Janssen to commercialize Yesintek in the U.S. by February 2025.

AstraZeneca's Enhertu approved for reimbursement in China amid ongoing probe

AstraZeneca’s Enhertu, a leading breast cancer treatment, has been approved for reimbursement by China’s state-run medical insurance, enhancing the company’s sales prospects amid an ongoing investigation involving some senior executives. The drug is one of 91 added to the National Reimbursement Drug List, effective January 1, alongside treatments from Johnson & Johnson, Bristol Myers Squibb, Roche, Sanofi, and Merck for various conditions.

hi-tech medical devices market poised for growth driven by innovation and sustainability

The global Hi-Tech Medical Devices Market is experiencing significant growth driven by technological advancements, changing consumer preferences, and a focus on sustainability. Key objectives include forecasting market size across regions, analyzing growth factors, and identifying opportunities for stakeholders. Major players in the market include Medtronic, Abbott Laboratories, and Johnson & Johnson, with a comprehensive analysis of competitive dynamics and market trends provided in the research report.

healthcare oem manufacturers market projected to reach 382 billion by 2032

The Healthcare OEM Manufacturers Market is projected to grow from USD 198.59 billion in 2023 to USD 382.10 billion by 2032, with a CAGR of 9.8%. Key players include Johnson & Johnson, G.E. Healthcare, and Siemens Healthcare, driven by rising R&D spending and technological advancements. The market faces challenges such as stringent regulatory compliance and product safety concerns.

healthcare sector anticipates surge in ipos and mergers by 2025

The healthcare sector is poised for a surge in IPOs and mergers by 2025, driven by optimism from executives despite geopolitical tensions being cited as the primary risk. Major deals, such as Johnson & Johnson's $13.1 billion acquisition of Shockwave Medical, underscore this growth, with 72% of professionals anticipating increased M&A activity, particularly in Europe. Additionally, nearly two-thirds expect a rise in healthcare IPOs, indicating a revitalized equity capital market.

global consumer health market projected to reach over 713 billion by 2033

The global consumer healthcare market is segmented by product types, including OTC pharmaceuticals, personal care products, and dietary supplements, with offline distribution channels expected to dominate. North America is projected to lead the market due to rising awareness of wellness products, while Asia Pacific is anticipated to grow rapidly, driven by increasing disposable incomes and a large elderly population. Key players include Johnson & Johnson, Procter and Gamble, and Pfizer, among others, with ongoing developments enhancing market dynamics.
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.